Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Raal

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Cardiovascular Journal of Africa|February 6, 2019
Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS)Dirk J Blom, Frederick Raal, Aslam Amod, et al.
BMJ Public Health|February 28, 2025
Evaluating the CURB-65 score for in-hospital mortality prediction in COVID-19 patients: insights into dysglycaemiaFarzahna Mohamed, Brent A Prim, Jarrod Zamparini, et al.
Lipids in Health and Disease|November 2, 2022
Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formationSundeep Ruder, Brett Mansfield, Andrew Ronald Immelman, et al.
Circulation|October 18, 2023
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical TrialFrederick Raal, Ronen Durst, Ran Bi, et al.
BMJ Open|July 16, 2014
Lower levels of high-density lipoprotein cholesterol in urban Africans presenting with communicable versus non-communicable forms of heart disease: the 'Heart of Soweto' hospital registry studyJasmine G Lyons, Karen Sliwa, Melinda J Carrington, et al.
Circulation|November 7, 2012
Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trialFrederick Raal, Rob Scott, Ransi Somaratne, et al.
Plos One|December 8, 2022
Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population: Analysis of an array of lipid metrics in an AWI-Gen sub-studyGodfred Agongo, Frederick Raal, Engelbert A Nonterah, et al.
European Heart Journal|August 28, 2023
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trialFrederick Raal, Nyda Fourie, Russell Scott, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 22, 2011
Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular diseaseOluwatoyin C Amira, Saraladevi Naicker, Pravin Manga, et al.
AIDS (London, England)|October 3, 2019
Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South AfricaAlana T Brennan, Kaitlyn M Berry, Sydney Rosen, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Cardiovascular Journal of Africa|February 6, 2019
Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS)Dirk J Blom, Frederick Raal, Aslam Amod, et al.
BMJ Public Health|February 28, 2025
Evaluating the CURB-65 score for in-hospital mortality prediction in COVID-19 patients: insights into dysglycaemiaFarzahna Mohamed, Brent A Prim, Jarrod Zamparini, et al.
Lipids in Health and Disease|November 2, 2022
Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formationSundeep Ruder, Brett Mansfield, Andrew Ronald Immelman, et al.
Circulation|October 18, 2023
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical TrialFrederick Raal, Ronen Durst, Ran Bi, et al.
BMJ Open|July 16, 2014
Lower levels of high-density lipoprotein cholesterol in urban Africans presenting with communicable versus non-communicable forms of heart disease: the 'Heart of Soweto' hospital registry studyJasmine G Lyons, Karen Sliwa, Melinda J Carrington, et al.
Circulation|November 7, 2012
Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trialFrederick Raal, Rob Scott, Ransi Somaratne, et al.
Plos One|December 8, 2022
Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population: Analysis of an array of lipid metrics in an AWI-Gen sub-studyGodfred Agongo, Frederick Raal, Engelbert A Nonterah, et al.
European Heart Journal|August 28, 2023
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trialFrederick Raal, Nyda Fourie, Russell Scott, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 22, 2011
Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular diseaseOluwatoyin C Amira, Saraladevi Naicker, Pravin Manga, et al.
AIDS (London, England)|October 3, 2019
Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South AfricaAlana T Brennan, Kaitlyn M Berry, Sydney Rosen, et al.
Pageof 5